As it has been verified that TLR4 expression was also significantly increased in human contusion specimens after traumatic brain injury [116], resatorvid and other small molecules inhibiting pathogenetic events mediated by TLR4 might represent promising candidates for therapy following traumatic brain injury in humans. The gene discussed is TLR4; the disease is brain injury.